 | • レポートコード：GIR201115314 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、腫瘍バイオマーカー検査の世界市場を調査対象にし、腫瘍バイオマーカー検査の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（前立腺特異抗原検査、CTC検査、アルファフェトプロテイン（AFP）検査、CA検査、HER2検査、BRCA検査、未分化リンパ腫キナーゼ（ALK）検査、EGFR突然変異検査、KRAS検査、その他）、用途別分析（肺がん、乳がん、大腸がん、前立腺がん、血液がん）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Abbott Laboratories, Inc.、Foundation Medicine Inc.、Becton Dickinson & Co.、Agilent Technologies、Danaher Corporation、AstraZeneca、LabCorp Of America Holdings、Cancer Genetics Inc.、Biocept Inc.、Illumina Inc.、Luminex Corporation、Myriad Genetics Inc.、NanoString Technologies Inc. ・企業別売上、市場シェア ・腫瘍バイオマーカー検査の地域別市場分析 ・腫瘍バイオマーカー検査の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・腫瘍バイオマーカー検査のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・腫瘍バイオマーカー検査のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・腫瘍バイオマーカー検査の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・腫瘍バイオマーカー検査の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・腫瘍バイオマーカー検査の種類別市場規模2015-2020：前立腺特異抗原検査、CTC検査、アルファフェトプロテイン（AFP）検査、CA検査、HER2検査、BRCA検査、未分化リンパ腫キナーゼ（ALK）検査、EGFR突然変異検査、KRAS検査、その他 ・腫瘍バイオマーカー検査の用途別市場規模2015-2020：肺がん、乳がん、大腸がん、前立腺がん、血液がん ・腫瘍バイオマーカー検査の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Tumor Biomarker Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tumor Biomarker Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tumor Biomarker Test market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tumor Biomarker Test market has been segmented into:
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others
By Application, Tumor Biomarker Test has been segmented into:
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tumor Biomarker Test market presented in the report. This section sheds light on the sales growth of different regional and country-level Tumor Biomarker Test markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tumor Biomarker Test market.
The report offers in-depth assessment of the growth and other aspects of the Tumor Biomarker Test market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Tumor Biomarker Test Market Share Analysis
Tumor Biomarker Test competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tumor Biomarker Test sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tumor Biomarker Test sales, revenue and market share for each player covered in this report.
The major players covered in Tumor Biomarker Test are:
Abbott Laboratories, Inc.
Foundation Medicine Inc.
Becton Dickinson & Co.
Agilent Technologies
Danaher Corporation
AstraZeneca
LabCorp Of America Holdings
Cancer Genetics Inc.
Biocept Inc.
Illumina Inc.
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.
Table of Contents
1 Tumor Biomarker Test Market Overview
1.1 Product Overview and Scope of Tumor Biomarker Test
1.2 Classification of Tumor Biomarker Test by Type
1.2.1 Global Tumor Biomarker Test Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Tumor Biomarker Test Revenue Market Share by Type in 2019
1.2.3 Prostate Specific Antigen Tests
1.2.4 CTC Tests
1.2.5 Alpha-Fetoprotein (AFP) Tests
1.2.6 CA Test
1.2.7 HER2 Tests
1.2.8 BRCA Test
1.2.9 Anaplastic Lymphoma Kinase (ALK) Tests
1.2.10 EGFR Mutation Tests
1.2.11 KRAS Test
1.2.12 Others
1.3 Global Tumor Biomarker Test Market by Application
1.3.1 Overview: Global Tumor Biomarker Test Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Lung cancer
1.3.3 Breast cancer
1.3.4 Colorectal
1.3.5 Prostate Cancer
1.3.6 Blood Cancer
1.4 Global Tumor Biomarker Test Market by Regions
1.4.1 Global Tumor Biomarker Test Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Tumor Biomarker Test (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Tumor Biomarker Test Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Tumor Biomarker Test Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tumor Biomarker Test Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Tumor Biomarker Test Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tumor Biomarker Test Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories, Inc.
2.1.1 Abbott Laboratories, Inc. Details
2.1.2 Abbott Laboratories, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories, Inc. SWOT Analysis
2.1.4 Abbott Laboratories, Inc. Product and Services
2.1.5 Abbott Laboratories, Inc. Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.2 Foundation Medicine Inc.
2.2.1 Foundation Medicine Inc. Details
2.2.2 Foundation Medicine Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Foundation Medicine Inc. SWOT Analysis
2.2.4 Foundation Medicine Inc. Product and Services
2.2.5 Foundation Medicine Inc. Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.3 Becton Dickinson & Co.
2.3.1 Becton Dickinson & Co. Details
2.3.2 Becton Dickinson & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Becton Dickinson & Co. SWOT Analysis
2.3.4 Becton Dickinson & Co. Product and Services
2.3.5 Becton Dickinson & Co. Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Agilent Technologies SWOT Analysis
2.4.4 Agilent Technologies Product and Services
2.4.5 Agilent Technologies Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.5 Danaher Corporation
2.5.1 Danaher Corporation Details
2.5.2 Danaher Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Danaher Corporation SWOT Analysis
2.5.4 Danaher Corporation Product and Services
2.5.5 Danaher Corporation Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.7 LabCorp Of America Holdings
2.7.1 LabCorp Of America Holdings Details
2.7.2 LabCorp Of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 LabCorp Of America Holdings SWOT Analysis
2.7.4 LabCorp Of America Holdings Product and Services
2.7.5 LabCorp Of America Holdings Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.8 Cancer Genetics Inc.
2.8.1 Cancer Genetics Inc. Details
2.8.2 Cancer Genetics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Cancer Genetics Inc. SWOT Analysis
2.8.4 Cancer Genetics Inc. Product and Services
2.8.5 Cancer Genetics Inc. Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biocept Inc.
2.9.1 Biocept Inc. Details
2.9.2 Biocept Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biocept Inc. SWOT Analysis
2.9.4 Biocept Inc. Product and Services
2.9.5 Biocept Inc. Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.10 Illumina Inc.
2.10.1 Illumina Inc. Details
2.10.2 Illumina Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Illumina Inc. SWOT Analysis
2.10.4 Illumina Inc. Product and Services
2.10.5 Illumina Inc. Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.11 Luminex Corporation
2.11.1 Luminex Corporation Details
2.11.2 Luminex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Luminex Corporation SWOT Analysis
2.11.4 Luminex Corporation Product and Services
2.11.5 Luminex Corporation Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.12 Myriad Genetics Inc.
2.12.1 Myriad Genetics Inc. Details
2.12.2 Myriad Genetics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Myriad Genetics Inc. SWOT Analysis
2.12.4 Myriad Genetics Inc. Product and Services
2.12.5 Myriad Genetics Inc. Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
2.13 NanoString Technologies Inc.
2.13.1 NanoString Technologies Inc. Details
2.13.2 NanoString Technologies Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 NanoString Technologies Inc. SWOT Analysis
2.13.4 NanoString Technologies Inc. Product and Services
2.13.5 NanoString Technologies Inc. Tumor Biomarker Test Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Tumor Biomarker Test Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Tumor Biomarker Test Players Market Share
3.2.2 Top 10 Tumor Biomarker Test Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Tumor Biomarker Test Revenue and Market Share by Regions
4.2 North America Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
4.3 Europe Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
4.5 South America Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
5 North America Tumor Biomarker Test Revenue by Countries
5.1 North America Tumor Biomarker Test Revenue by Countries (2015-2020)
5.2 USA Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
5.3 Canada Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
5.4 Mexico Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
6 Europe Tumor Biomarker Test Revenue by Countries
6.1 Europe Tumor Biomarker Test Revenue by Countries (2015-2020)
6.2 Germany Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
6.3 UK Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
6.4 France Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
6.5 Russia Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
6.6 Italy Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Tumor Biomarker Test Revenue by Countries
7.1 Asia-Pacific Tumor Biomarker Test Revenue by Countries (2015-2020)
7.2 China Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
7.3 Japan Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
7.4 Korea Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
7.5 India Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
8 South America Tumor Biomarker Test Revenue by Countries
8.1 South America Tumor Biomarker Test Revenue by Countries (2015-2020)
8.2 Brazil Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
8.3 Argentina Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Tumor Biomarker Test by Countries
9.1 Middle East & Africa Tumor Biomarker Test Revenue by Countries (2015-2020)
9.2 Saudi Arabia Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
9.3 UAE Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
9.4 Egypt Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
9.5 South Africa Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Tumor Biomarker Test Revenue and Market Share by Type (2015-2020)
10.2 Global Tumor Biomarker Test Market Forecast by Type (2019-2024)
10.3 Prostate Specific Antigen Tests Revenue Growth Rate (2015-2025)
10.4 CTC Tests Revenue Growth Rate (2015-2025)
10.5 Alpha-Fetoprotein (AFP) Tests Revenue Growth Rate (2015-2025)
10.6 CA Test Revenue Growth Rate (2015-2025)
10.7 HER2 Tests Revenue Growth Rate (2015-2025)
10.8 BRCA Test Revenue Growth Rate (2015-2025)
10.9 Anaplastic Lymphoma Kinase (ALK) Tests Revenue Growth Rate (2015-2025)
10.10 EGFR Mutation Tests Revenue Growth Rate (2015-2025)
10.11 KRAS Test Revenue Growth Rate (2015-2025)
10.12 Others Revenue Growth Rate (2015-2025)
11 Global Tumor Biomarker Test Market Segment by Application
11.1 Global Tumor Biomarker Test Revenue Market Share by Application (2015-2020)
11.2 Tumor Biomarker Test Market Forecast by Application (2019-2024)
11.3 Lung cancer Revenue Growth (2015-2020)
11.4 Breast cancer Revenue Growth (2015-2020)
11.5 Colorectal Revenue Growth (2015-2020)
11.6 Prostate Cancer Revenue Growth (2015-2020)
11.7 Blood Cancer Revenue Growth (2015-2020)
12 Global Tumor Biomarker Test Market Size Forecast (2021-2025)
12.1 Global Tumor Biomarker Test Market Size Forecast (2021-2025)
12.2 Global Tumor Biomarker Test Market Forecast by Regions (2021-2025)
12.3 North America Tumor Biomarker Test Revenue Market Forecast (2021-2025)
12.4 Europe Tumor Biomarker Test Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Tumor Biomarker Test Revenue Market Forecast (2021-2025)
12.6 South America Tumor Biomarker Test Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Tumor Biomarker Test Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Tumor Biomarker Test Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tumor Biomarker Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tumor Biomarker Test Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Tumor Biomarker Test Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories, Inc. Corporate Information, Location and Competitors
Table 6. Abbott Laboratories, Inc. Tumor Biomarker Test Major Business
Table 7. Abbott Laboratories, Inc. Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories, Inc. SWOT Analysis
Table 9. Abbott Laboratories, Inc. Tumor Biomarker Test Product and Solutions
Table 10. Abbott Laboratories, Inc. Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Foundation Medicine Inc. Corporate Information, Location and Competitors
Table 12. Foundation Medicine Inc. Tumor Biomarker Test Major Business
Table 13. Foundation Medicine Inc. Tumor Biomarker Test Total Revenue (USD Million) (2018-2019)
Table 14. Foundation Medicine Inc. SWOT Analysis
Table 15. Foundation Medicine Inc. Tumor Biomarker Test Product and Solutions
Table 16. Foundation Medicine Inc. Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Becton Dickinson & Co. Corporate Information, Location and Competitors
Table 18. Becton Dickinson & Co. Tumor Biomarker Test Major Business
Table 19. Becton Dickinson & Co. Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 20. Becton Dickinson & Co. SWOT Analysis
Table 21. Becton Dickinson & Co. Tumor Biomarker Test Product and Solutions
Table 22. Becton Dickinson & Co. Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Agilent Technologies Corporate Information, Location and Competitors
Table 24. Agilent Technologies Tumor Biomarker Test Major Business
Table 25. Agilent Technologies Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 26. Agilent Technologies SWOT Analysis
Table 27. Agilent Technologies Tumor Biomarker Test Product and Solutions
Table 28. Agilent Technologies Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Danaher Corporation Corporate Information, Location and Competitors
Table 30. Danaher Corporation Tumor Biomarker Test Major Business
Table 31. Danaher Corporation Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 32. Danaher Corporation SWOT Analysis
Table 33. Danaher Corporation Tumor Biomarker Test Product and Solutions
Table 34. Danaher Corporation Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. AstraZeneca Corporate Information, Location and Competitors
Table 36. AstraZeneca Tumor Biomarker Test Major Business
Table 37. AstraZeneca Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 38. AstraZeneca SWOT Analysis
Table 39. AstraZeneca Tumor Biomarker Test Product and Solutions
Table 40. AstraZeneca Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. LabCorp Of America Holdings Corporate Information, Location and Competitors
Table 42. LabCorp Of America Holdings Tumor Biomarker Test Major Business
Table 43. LabCorp Of America Holdings Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 44. LabCorp Of America Holdings SWOT Analysis
Table 45. LabCorp Of America Holdings Tumor Biomarker Test Product and Solutions
Table 46. LabCorp Of America Holdings Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Cancer Genetics Inc. Corporate Information, Location and Competitors
Table 48. Cancer Genetics Inc. Tumor Biomarker Test Major Business
Table 49. Cancer Genetics Inc. Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 50. Cancer Genetics Inc. SWOT Analysis
Table 51. Cancer Genetics Inc. Tumor Biomarker Test Product and Solutions
Table 52. Cancer Genetics Inc. Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Biocept Inc. Corporate Information, Location and Competitors
Table 54. Biocept Inc. Tumor Biomarker Test Major Business
Table 55. Biocept Inc. Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 56. Biocept Inc. SWOT Analysis
Table 57. Biocept Inc. Tumor Biomarker Test Product and Solutions
Table 58. Biocept Inc. Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Illumina Inc. Corporate Information, Location and Competitors
Table 60. Illumina Inc. Tumor Biomarker Test Major Business
Table 61. Illumina Inc. Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 62. Illumina Inc. SWOT Analysis
Table 63. Illumina Inc. Tumor Biomarker Test Product and Solutions
Table 64. Illumina Inc. Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Luminex Corporation Corporate Information, Location and Competitors
Table 66. Luminex Corporation Tumor Biomarker Test Major Business
Table 67. Luminex Corporation Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 68. Luminex Corporation SWOT Analysis
Table 69. Luminex Corporation Tumor Biomarker Test Product and Solutions
Table 70. Luminex Corporation Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Myriad Genetics Inc. Corporate Information, Location and Competitors
Table 72. Myriad Genetics Inc. Tumor Biomarker Test Major Business
Table 73. Myriad Genetics Inc. Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 74. Myriad Genetics Inc. SWOT Analysis
Table 75. Myriad Genetics Inc. Tumor Biomarker Test Product and Solutions
Table 76. Myriad Genetics Inc. Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. NanoString Technologies Inc. Corporate Information, Location and Competitors
Table 78. NanoString Technologies Inc. Tumor Biomarker Test Major Business
Table 79. NanoString Technologies Inc. Tumor Biomarker Test Total Revenue (USD Million) (2017-2018)
Table 80. NanoString Technologies Inc. SWOT Analysis
Table 81. NanoString Technologies Inc. Tumor Biomarker Test Product and Solutions
Table 82. NanoString Technologies Inc. Tumor Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Tumor Biomarker Test Revenue (Million USD) by Players (2015-2020)
Table 84. Global Tumor Biomarker Test Revenue Share by Players (2015-2020)
Table 85. Global Tumor Biomarker Test Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Tumor Biomarker Test Revenue Market Share by Regions (2015-2020)
Table 87. North America Tumor Biomarker Test Revenue by Countries (2015-2020)
Table 88. North America Tumor Biomarker Test Revenue Market Share by Countries (2015-2020)
Table 89. Europe Tumor Biomarker Test Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Tumor Biomarker Test Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Tumor Biomarker Test Revenue by Countries (2015-2020)
Table 92. South America Tumor Biomarker Test Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Tumor Biomarker Test Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Tumor Biomarker Test Revenue Market Share by Countries (2015-2020)
Table 95. Global Tumor Biomarker Test Revenue (Million USD) by Type (2015-2020)
Table 96. Global Tumor Biomarker Test Revenue Share by Type (2015-2020)
Table 97. Global Tumor Biomarker Test Revenue Forecast by Type (2021-2025)
Table 98. Global Tumor Biomarker Test Revenue by Application (2015-2020)
Table 99. Global Tumor Biomarker Test Revenue Share by Application (2015-2020)
Table 100. Global Tumor Biomarker Test Revenue Forecast by Application (2021-2025)
Table 101. Global Tumor Biomarker Test Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Tumor Biomarker Test Picture
Figure 2. Global Tumor Biomarker Test Revenue Market Share by Type in 2019
Figure 3. Prostate Specific Antigen Tests Picture
Figure 4. CTC Tests Picture
Figure 5. Alpha-Fetoprotein (AFP) Tests Picture
Figure 6. CA Test Picture
Figure 7. HER2 Tests Picture
Figure 8. BRCA Test Picture
Figure 9. Anaplastic Lymphoma Kinase (ALK) Tests Picture
Figure 10. EGFR Mutation Tests Picture
Figure 11. KRAS Test Picture
Figure 12. Others Picture
Figure 13. Tumor Biomarker Test Revenue Market Share by Application in 2019
Figure 14. Lung cancer Picture
Figure 15. Breast cancer Picture
Figure 16. Colorectal Picture
Figure 17. Prostate Cancer Picture
Figure 18. Blood Cancer Picture
Figure 19. Global Tumor Biomarker Test Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. North America Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Europe Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Asia-Pacific Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. South America Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 24. Middle East and Africa Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 25. Global Tumor Biomarker Test Revenue (Million USD) and Growth Rate (2015-2025)
Figure 26. Global Tumor Biomarker Test Revenue Share by Players in 2019
Figure 27. Global Top 5 Players Tumor Biomarker Test Revenue Market Share in 2019
Figure 28. Global Top 10 Players Tumor Biomarker Test Revenue Market Share in 2019
Figure 29. Key Players Market Share Trend
Figure 30. Global Tumor Biomarker Test Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 31. Global Tumor Biomarker Test Revenue Market Share by Regions (2015-2020)
Figure 32. Global Tumor Biomarker Test Revenue Market Share by Regions in 2018
Figure 33. North America Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 34. Europe Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 35. Asia-Pacific Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 36. South America Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 37. Middle East and Africa Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 38. North America Tumor Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 39. North America Tumor Biomarker Test Revenue Market Share by Countries in 2019
Figure 40. USA Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 41. Canada Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 42. Mexico Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 43. Europe Tumor Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 44. Europe Tumor Biomarker Test Revenue Market Share by Countries in 2019
Figure 45. Germany Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 46. UK Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 47. France Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 48. Russia Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 49. Italy Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 50. Asia-Pacific Tumor Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 51. Asia-Pacific Tumor Biomarker Test Revenue Market Share by Countries in 2019
Figure 52. China Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 53. Japan Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 54. Korea Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 55. India Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 56. Southeast Asia Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 57. South America Tumor Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 58. South America Tumor Biomarker Test Revenue Market Share by Countries in 2019
Figure 59. Brazil Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 60. Argentina Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 61. Middle East and Africa Tumor Biomarker Test Revenue Market Share by Countries (2015-2020)
Figure 62. Middle East and Africa Tumor Biomarker Test Revenue Market Share by Countries in 2019
Figure 63. Saudi Arabia Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 64. UAE Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 65. Egypt Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 66. South Africa Tumor Biomarker Test Revenue and Growth Rate (2015-2020)
Figure 67. Global Tumor Biomarker Test Revenue Share by Type (2015-2020)
Figure 68. Global Tumor Biomarker Test Revenue Share by Type in 2019
Figure 69. Global Tumor Biomarker Test Market Share Forecast by Type (2021-2025)
Figure 70. Global Prostate Specific Antigen Tests Revenue Growth Rate (2015-2020)
Figure 71. Global CTC Tests Revenue Growth Rate (2015-2020)
Figure 72. Global Alpha-Fetoprotein (AFP) Tests Revenue Growth Rate (2015-2020)
Figure 73. Global CA Test Revenue Growth Rate (2015-2020)
Figure 74. Global HER2 Tests Revenue Growth Rate (2015-2020)
Figure 75. Global BRCA Test Revenue Growth Rate (2015-2020)
Figure 76. Global Anaplastic Lymphoma Kinase (ALK) Tests Revenue Growth Rate (2015-2020)
Figure 77. Global EGFR Mutation Tests Revenue Growth Rate (2015-2020)
Figure 78. Global KRAS Test Revenue Growth Rate (2015-2020)
Figure 79. Global Others Revenue Growth Rate (2015-2020)
Figure 80. Global Tumor Biomarker Test Revenue Share by Application (2015-2020)
Figure 81. Global Tumor Biomarker Test Revenue Share by Application in 2019
Figure 82. Global Tumor Biomarker Test Market Share Forecast by Application (2021-2025)
Figure 83. Global Lung cancer Revenue Growth Rate (2015-2020)
Figure 84. Global Breast cancer Revenue Growth Rate (2015-2020)
Figure 85. Global Colorectal Revenue Growth Rate (2015-2020)
Figure 86. Global Prostate Cancer Revenue Growth Rate (2015-2020)
Figure 87. Global Blood Cancer Revenue Growth Rate (2015-2020)
Figure 88. Global Tumor Biomarker Test Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 89. Global Tumor Biomarker Test Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 90. Global Tumor Biomarker Test Revenue Market Share Forecast by Regions (2021-2025)
Figure 91. North America Tumor Biomarker Test Revenue Market Forecast (2021-2025)
Figure 92. Europe Tumor Biomarker Test Revenue Market Forecast (2021-2025)
Figure 93. Asia-Pacific Tumor Biomarker Test Revenue Market Forecast (2021-2025)
Figure 94. South America Tumor Biomarker Test Revenue Market Forecast (2021-2025)
Figure 95. Middle East and Africa Tumor Biomarker Test Revenue Market Forecast (2021-2025)
Figure 96. Sales Channel: Direct Channel vs Indirect Channel
PD-L1バイオマーカー検査プラットフォームの世界市場 2020年 Market Overview The PD-L1 Biomarker Testing Platform market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- 液体生検用循環バイオマーカーの世界市場 2020年 Market Overview The global Circulating Biomarker for Liquid Biopsy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Circu…
- 肝炎診断テストの世界市場 2020年 Market Overview The global Hepatitis Diagnostics Test market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis Diagnost…
- NGSベース監視・診断試験の世界市場 2020年 Market Overview The NGS-Based Monitoring and Diagnostic Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- ボーカルバイオマーカーの世界市場 2020年 Market Overview The global Vocal Biomarker market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vocal Biomarker market report…